Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine loading dose study for rigid bronchoscopy under general anesthesia
ChiCTR2200056626Phase 4Recruiting
- Sponsor
- Xi'an Chest Hospital
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in airway diseases (3 arms), sponsored by Xi'an Chest Hospital. Primary endpoints: Mean arterial pressure, Heart rate and 5 more. Started Feb 2022; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
airway diseases
Beyond the preview
Go deeper on ChiCTR2200056626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056626.